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The demand of frozen-dough products has increased notably in the baking industry. 
Nowadays, no appropriate industrial baker’s yeast with optimal gassing capacity in 
frozen dough is however available, and it is unlikely that classical breeding programs 
could provide significant improvements of this trait. Antifreeze proteins, found in 
diverse organisms, display the ability to inhibit the growth of ice, allowing them to 5 
survive at temperatures below 0ºC. In this study, we expressed a recombinant antifreeze 
peptide GS-5 from the polar fish grubby sculpin (Myoxocephalus aenaeus) in laboratory 
and industrial baker’s yeast strains of Saccharomyces cerevisiae. Production of the 
recombinant protein increased freezing tolerance in both strains tested. Furthermore, 
expression of GS-5 encoding gene enhanced notably gassing rate and total gas 10 
production in frozen and frozen sweet dough. These effects are unlikely due to reduced 
osmotic damage during freezing/thawing, because recombinant cells showed similar 
growth behavior than the parental under hypermosmotic stress conditions. 
 
KEYWORDS: Baker’s yeast; Saccharomyces cerevisiae; Type I antifreeze 15 
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INTRODUCTION 
The ability of yeast to cope with and respond to freezing temperatures is a key point 
in the bread making process, and improvement of yeast freeze-tolerance has become a 
major focus of attention during last years (for a review see 1). This interest has 
increased by the enormous expansion of the frozen-dough market. Presently, the so-5 
called frozen-dough technology makes up 10% of the sales of baked products in Europe 
and 25-30% worldwide, and it is expected a growing demand in the next future. 
Freezing is often a lethal stress for yeast cells, as it causes denaturalization of 
macromolecules, ruptures of cell membranes and osmotic shrinkage with loss of water 
and turgor (2). During frozen storage, ice crystal growth further deteriorates the plasma 10 
membrane and impairs activity in different cellular systems. Finally, during the thawing 
process, cells can suffer oxidative stress (3). As a consequence, the gassing power of 
yeast cells is reduced, increasing proofing time and lowering bread volume. 
To overcome these problems, it is common for bakers to increase yeast dosages in 
these products by 4-10% above normal. However, this practice increases process cost 15 
and affects negatively the taste and texture. Consequently, the development of yeast 
strains with better gassing power in frozen dough has a great economic interest. 
Nowadays, no appropriate industrial baker’s yeast with these desired properties is 
however available, and it is unlikely that classical breeding programs could provide 
significant improvements of these characteristics. Indeed, our limited understanding of 20 
physiological and genetic determinants of freezing tolerance suggests that they are 
under control of multiple genes and complex regulatory mechanisms (4). 
In this scenario, the ability to transform baker’s yeast by recombinant DNA 
technology has opened the possibilities to manipulate just a single gene or pathway 
without altering other key or valuable genes for technological purposes (5, 6). The 25 
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transfer of heterologous genes to S. cerevisiae has also meant that there is now the 
possibility of using baker’s yeast as a cell factory. This has allowed in the past decade 
the development of industrial strains with unsuspected properties, giving to a new 
generation of baker’s yeast (5). 
It has been reported that Antifreeze Proteins (AFPs), play a major role in the freeze 5 
avoidance or freeze tolerance response of a wide range of organisms including bacteria, 
fungi, arthropods, plants and fish (for reviews see 7-9). The AFPs from polar fish 
species have been the most extensively characterized and are grouped into four classes 
on the basis of their amino acid composition. Type I is the smallest and simplest, which 
structure corresponds with an amphipathic alanine-rich α-helix chain (10). Several 10 
representatives of this class of protein have been described and all contain between 
three and five imperfect copies of an amino acid sequence motif composed mainly of 
alanine residues. These proteins fold with pairs of polar amino acid residues, known as 
ice-binding motifs (11), spaced at regular intervals along the polar face of the helix. 
These polar residues form hydrogen bonds with ice due to a lattice-matching 15 
mechanism (12), and the protein inhibits water deposition onto these surfaces of the ice 
crystal due to steric hindrance. 
The activity of AFPs has attracted the attention of food biotechnologists interested in 
engineering freeze hardiness. Antifreeze proteins may inhibit recrystallization during 
freezing, frozen storage and thawing, thus preserving food texture and minimizing loss 20 
of essential nutrients (13). AFPs are naturally present in many foods consumed as part 
of the human diet and there are no evidences of adverse health effects (14). In the case 
of fish AFPs, which intake is estimated as substantial in most northerly regions, is also 
reasonable to infer a lack of allergenicity (14). 
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AFPs can be introduced into food products either by exogenous addition or by gene 
transfer. In this late case, the apparent simplicity of structure of the type I AFPs makes 
them particularly attractive, because it allows a relatively easy genetic manipulation. 
However, their small size (Mr 3,000-5,000) and lack of globular tertiary structure have 
apparently rendered this class of protein susceptible to degradation when expressed in 5 
heterologous host systems such as Escherichia coli, yeast, Drosophila and plants (10, 
15, 16). 
Here we report how heterologous expression of a type I, alanine-rich AFP (17), 
isolated from the polar fish known as grubby sculpin (Myoxocephalus aenaeus) 
provides a new alternative to face loss of viability of baker’s yeast cells upon freezing 10 
and frozen storage. GS-5 production through the secretory pathway using the prepro α-
mating factor sequence of S. cerevisiae also enabled to increase gas production in a 
frozen liquid dough model system. 
 
MATERIALS AND METHODS 15 
Yeast strains and culture media. The industrial baker’s yeast HS13 Ura- (Lesaffre 
International, Lille, France) and the laboratory W303-1A (MATa ade2-1 his3-11,15 
leu2-3,112 trp1-1 ura3-1 can1-100 GAL mal SUC2) wild-type strain (18) were used 
throughout this study. Yeast biomass was prepared by cultivating cells (7.6 units of 
OD600) on molasses (5.0 g of beet molasses (49% sucrose), 0.5 g of ammonium 20 
phosphate, 26.0 g of agar and 20 µg of biotin per liter; adjusted to a final pH 5.0) plates 
(140-mm diameter) for 20 h at 30ºC. Then yeast cells were recovered by washing the 
plate surface with 2 x 10 ml of distilled water and the yeast suspension was poured into 
a tube. After centrifugation, the yeast cake was washed twice with distilled water (4ºC), 
resuspended in saline solution containing 27 g/l of NaCl, vortexed, and the OD600 of the 25 
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resulting suspension measured. The final yeast concentration was adjusted to 30 mg 
(dry weight) per ml (OD600 = 1 equals 0.35 mg cells dry weight/ml). Fifteen ml of the 
yeast mixture was poured into a 250-ml screw cap graduated bottle and placed in a 30ºC 
water bath. After 15 min, 15 ml of 30ºC liquid dough (LD) was added, which results in 
a concentration of yeast similar to that used in traditional bread dough (around 2%, flour 5 
basis), and the production of CO2 by the yeast cells measured. The LD model system 
was prepared as previously reported (19). Yeast cells were also grown in SD [0.17% 
yeast nitrogen base without amino acids (DIFCO) plus 0.5% ammonium sulphate and 
2% glucose] supplemented with the appropriate concentrations of essential nutrients 
(20) or YPD (1% yeast extract, 2% peptone, 2% glucose). Cells were grown routinely in 10 
500 ml Erlenmeyer flasks at 30ºC on an orbital shaker (250 rpm). 
Phenotype experiments were made by adjusting exponential cultures to OD600 = 0.3 
and spotting serial dilutions onto SD agar plates containing NaCl (0.7 M) or KCl (1.4 
M). Plates were incubated at 30ºC for 2-6 days. For freeze tolerance assays, cells (15 
mg dry weight per ml) were inoculated in LD and the suspension was divided in 1 ml 15 
portions and transferred directly to -20ºC. After different times, aliquots were thawing 
at 30ºC for 30 min and the percent of viable cells was measured by counting the number 
of colonies onto YPD plates. 
Escherichia coli DH10B host strain was grown in Luria-Bertani (LB) medium (0.5% 
yeast extract, 1% peptone, 0.5% NaCl) supplemented with ampicillin (50mg/L). 20 
Antibiotics and auxotrophic requirements were filter-sterilized and added to autoclaved 
medium. 
DNA manipulations and plasmids. Plasmid YEpGS5 (URA3), which contains the 
GS-5 expression cassette was constructed as follows: fragments containing sequences of 
the yeast pheromone α-factor (MFα1) prepro region (-13 to +273), PGK1 terminator, 25 
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TPGK1 (+1064 to +1544) and ACT1 promoter, PACT1 (–497 to +11) were obtained by 
standard PCR using specific synthetic oligonucleotides (Table 1). The amplified PACT1 
fragment was digested with BamHI and EcoRI and cloned into the pBlueScriptII SK 
vector (Stratagen, La Jolla, CA), obtaining the plasmid pBS-PACT. Then, the amplified 
prepro α-factor sequence was cloned into the pGEM-T Easy Vector (Promega, 5 
Madison, WI), treated with EcoRI and HindIII, and inserted into the pBS-PACT plasmid, 
resulting in plasmid pBS-PACTα.  
The GS-5 coding DNA fragment was synthesized by PCR using first two specific 60-
bp oligonucleotides, GSL-1 and GSL-2, designed to overlap in 10 bp (Table 1). After a 
first cycle of primer extension, amplification of GS-5 DNA was continued using 10 
primers GSC-1 and GSC-2 (Table 1). The amplified fragment was subcloned into the 
pGEM-T Easy Vector (Promega), obtaining the plasmid pGEM-GS5. This was digested 
with HindIII and ClaI, and the released GS-5 fragment was inserted into the pBS-
PACTα plasmid, obtaining the plasmid pBS-PACTαGS5. This was treated with ClaI and 
SalI, and used to accommodate the TPGK1 fragment previously digested with the same 15 
set of enzymes, obtaining the plasmid pBS-PACTαGS5TPGK. Finally, the GS-5 
expression cassette was accommodated into the vector YEplac195 (21) by digestion 
with BamHI and SalI. 
Yeast cells were transformed according to (22) and transformants were selected by 
auxotrophic complementation in SD plates. E. coli was transformed by electroporation 20 
following the manufacturer’s instructions (Eppendorf). 
Gas production measurements. Yeast biomass was inoculated in LD, incubated at 
30ºC with low shaking (80 rpm), and the amount of CO2 evolved recorded in a home-
made fermentometer (Chittick apparatus) by measuring the displacement of a 
manometric solution placed in a graduated buret (23). The manometric solution 25 
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contained 10% CaCl2 and 0.5% CuCl2 at pH < 5. CO2 production was recorded at 20 
min intervals for 180 min. Values are expressed as ml of CO2 per mg of yeast cells, and 
were normalized to the initial dry weight of the yeast sample tested. We assume that 
yeast growth over the course of the experiment is almost identical for all the strains 
tested.  5 
 
RESULTS AND DISCUSSION 
Construction of a yeast expression vector containing the GS-5 coding sequence. 
The mature form of grubby sculpin GS-5 type I AFP contains only 33 amino acids, 
making practical to synthesize the gene de novo, as a 99 nucleotide DNA fragment. The 10 
strategy relied on commercial synthesis of two 10 bp-overlapping oligonucleotides, 
which contain the GS-5 sequence adjusted to the S. cerevisiae preferred codon usage 
(24). In addition, the oligonucleotides were designed to remove the ATG of the wild-
type GS-5 encoding sequence by the change of A to T and to add a stop codon. This 
change allows the in-frame expression of the GS-5 sequence and introduces a single 15 
replacement at residue 1 from methionine to leucine. Nucleotides at the 5’-ends for the 
restriction sites HindIII and ClaI, were also included to allow its later manipulation. 
After an extension phase of the assembled oligonucleotides, the complete fragment was 
amplified by PCR, ligated into an appropriate vector and the nucleotide sequence of the 
insert was determined to confirm its identity. A schematic representation of the strategy 20 
of synthesis and cloning of the AFP is shown in Figure 1. 
To obtain the expression of the recombinant peptide, the GS-5 sequence was placed 
under the control of the S. cerevisiae ACT1 promoter, a strong constitutive promoter 
widely used for the production of heterologous proteins in baker’s yeast (25, 26). The 
expression cassette also comprised the terminator of the PGK1 gene and the signal 25 
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sequence and leader region of the yeast prepro α-mating factor (MFα1 gene), which 
was fused in-frame upstream of the GS-5 sequence (Figure 1). The prepro α-factor 
sequence is an efficient secretion vehicle for heterologous proteins, as it is processed 
through the secretory pathway and digested by specific proteases, releasing thus the 
biologically active protein (27). The final construct (Figure 1) generated in the shuttle 5 
vector YEplac195 (21) was used to transform the laboratory W303-1A and the 
industrial HS13 strain. Transformants were selected by auxotrophic complementation 
and the functionality of the AFP-producing strains analyzed. 
Production of the recombinant AFP GS-5 increases freeze tolerance in yeast. 
Transformants of each strain under assay were selected for testing the ability of 10 
recombinant GS-5 to enhance freeze tolerance in yeast. Cells were inoculated in a flour-
free liquid dough model system (LD), shifted to -20ºC, and at different times, samples 
were thawed and the number of viable cells was determined by their colony-forming 
ability. We choose the LD system because it mimics the main nutrient composition of 
bread dough and permit the easy collection of isolated yeast cells and testing of 15 
functional properties (19). In all cases, yeast cells transformed with the empty plasmid 
YEplac195 were used as control. As it can be seen (Figure 2), the two strains analyzed 
differed in their susceptibility to freezing and frozen storage. Cells of the industrial 
HS13 strain showed a rapid and strong loss of viability, even after only 1 day at -20ºC. 
On the contrary, at least 50% of the laboratory wild-type strain cells survived 13 days at 20 
this temperature. The degree of freeze tolerance acquired by overexpression of GS-5 
was also dependent on the strain tested. Although production of the AFP in the 
laboratory strain resulted in a certain protection against freeze damage, this effect was 
significantly larger in transformants of the HS13 strain (Figure 2). As an example, the 
number of viable cells in YEpGS5 transformants of the HS13 strain was 32-fold higher 25 
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than in the wild-type after 13 days at -20ºC. Thus the expression of the AFP GS-5 
increases freeze tolerance in yeast, but the magnitude of this response appears to 
correlate with the basal sensitivity of the yeast strain assayed. 
We also tested if the increase of freeze tolerance observed by expression of the AFP 
GS-5 in the industrial strain, determines an enhanced CO2 production in frozen dough. 5 
Again, cells were inoculated in the LD model system and their gassing power tested 
after freezing at -20ºC and frozen storage (Figure 3). CO2 production by HS13 cells was 
reduced markedly after freezing for 3 h and thawing (see point marked as 0’ in Figure 
3). This loss was similar in either of the transformants tested, around 30% with respect 
to unfrozen samples, suggesting that the recombinant AFP does not impart 10 
osmoprotection. Effects on leavening activity of yeast cells upon freezing and thawing 
has been mainly attributed to desiccation and electrolyte release giving to hyperosmotic 
stress (28). On the contrary, expression of the antifreeze peptide GS-5 enhanced gas 
production capacity during frozen storage. Indeed, after 40 days at -20ºC the production 
of CO2 in samples inoculated with cells of the YEpGS5 transformant was 30% higher 15 
than that found in control (YEplac195) samples (Figure 3). Nevertheless, these 
differences were less pronounced than those seen in the viable cells assay (Figure 2). 
Thus, it seems that a number of cells unable to form colonies on YPD plates are still 
metabolically active, at least in terms of CO2 production. 
The production of the AFP GS-5 does not confer osmotic stress resistance in 20 
yeast. Studies by Meijer et al. (29) reported that expression of fish AFPs in E. coli has 
an osmoprotective function. This property has been attributed to an interaction between 
antifreeze peptides and membrane lipids, which would reduce membrane permeability 
and inhibit leakage from cells (30). However, the CO2 production data reported in this 
study (Figure 3) did not appear to support a functional role of the AFP GS-5 in 25 
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osmoprotection. In order to clarify this point, we tested if expression of the recombinant 
antifreeze peptide could also confer improved osmotolerance in baker’s yeast cells. The 
ability of yeast to withstand increasing osmotic pressures is a key point in the bread 
making process, and improvement of yeast osmotolerance has become a main issue 
during years (1). As it is shown in Figure 4, production of the AFP by yeast host cells of 5 
the W303-1A strain produced no significant growth improvement on media containing 
high concentrations of NaCl or KCl. No effects were also found on growth of 
transformants of the industrial HS13 strain. 
In conclusion, the expression of AFPs in baker’s yeast appears to be a promising 
strategy to increase cell viability in frozen dough. However, it seems unlikely that this 10 
approach could be successful to provide osmoprotection. At present stage, production of 
a native form of the antifreeze peptide GS-5 from the polar fish grubby sculpin allowed 
a modest but significant improvement in fermentative performance. Further increases in 
freeze tolerance would be however required to ensure satisfactory leavening of frozen 
dough at the conventional yeast doses employed in unfrozen products. Directed 15 
evolution by random mutation based on the GS-5 AFP could be thus an attractive 
technique to provide additional freeze protection. Experiments in this line are currently 
in progress. 
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Figure Captions 
Figure 1. Partial DNA sequence of the insert contained in plasmid YEpGS5 and 
construction of the GS-5 expression cassette. The DNA sequence of the yeast prepro α-
factor fused in-frame upstream of the GS-5 sequence, and adjacent nucleotides is 
shown. The deduced amino acid sequence of the recombinant protein and mature GS-5 5 
(bold) is shown below. Unique restriction sites are shown in bold and underlined. The 
start and stop codon are marked by *. Strategy to construct plasmid YEpGS5 is detailed 
in Material and methods. Oligonucleotides used for PCR amplifications are shown in 
Table 1. PACT1, ACT1 promoter. prepro α-factor, signal sequence and leader region of 
the yeast prepro α-mating factor (MFα1 gene). TPGK1, PGK1 terminator. ori, replication 10 
origin in E. coli. MCS, multicloning site. ori 2 µm, replication origin in S. cerevisiae. 
lacZ, a reporter gene. URA3 and ampR are selectable markers, used in S. cerevisiae and 
E. coli, respectively. Plasmid and fragment sizes are not to scale. 
 
Figure 2. Viability during freezing and frozen storage of transformants of S. cerevisiae 15 
strains expressing the AFP GS-5. Yeast strains HS13 and W303-1A were transformed 
with plasmids YEpGS5 (●) or YEplac195 (○) and analyzed for freeze tolerance. The 
graph represents the log of colony forming units (CFU) of S. cerevisiae per ml after 
different periods of frozen storage. Unfrozen samples were used as control (0 days). 
Cells were grown, shifted to -20ºC, thawing and platted onto YPD solid medium as 20 
described in the Materials and methods section. Values represent the means of at least 
three independent experiments. The error associated with the points was calculated by 
using the formula: (1.96 × SD) / √n, where n is the number of measurements. 
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Figure 3. Effect of freezing and frozen storage on CO2 production by HS13 baker’s 
yeast cells producing the AFP GS-5. Liquid dough (LD) samples were inoculated with 
cells of the YEplac195 (○) or YEpGS5 (●) transformants, shifted to -20ºC and stored at 
the same temperature for 3 h (0’) or up to 40 days. After each storage stage the CO2 
production level was tested in a home-made fermentometer. Unfrozen samples were 5 
used as control (0 days). Values are given as means of three independent experiments. 
The error associated with the points was < 5% of the value of the point.  dw, dry weight. 
 
Figure 4. The heterologous expression of the AFP GS-5 does not alter growth of yeast 
cells under hyperosmotic conditions. Cells of the W303-1A and HS13 strains were 10 
transformed with plasmids YEpGS5 (GS-5) or YEplac195 (wt) and assayed for growth 
in the presence of 0.7 M NaCl or 1.4 M KCl. Cultures were grown in SD at 30ºC until 
early-exponential phase and adjusted to OD600 = 0.3. Serial dilutions (1-10-3) of the 
adjusted cultures were spotted (3 µl) onto SD plates containing the indicated solutes and 
incubated at 30ºC for 2 to 6 days, respectively. 15 
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Table 1. Oligonucleotides used in this study 
 
    Primer Sequence 5´ to 3´  Comments 
    
    
Alpha-1 AACGAaTtcAAGAATGAGATTTCC  PCR, forward MFα1 (EcoRI site underlined) 
Alpha-2 ATGCCAAGCTTCAGCCTC  PCR, reverse MFα1  (HindIII site underlined) 
PGK-1 ACGAAGTTGTCAAGAGCTCTGCTGC  PCR, forward tPGK1 
PGK-2 ATCCTTgTCGAcAGCTTTAACGAAC
GC 
 PCR, reverse tPGK1 (SalI site underlined) 
ACT-1 CCTACATTCTTCCTTATCGGATCC  PCR, forward pACT1 (BamHI site underlined) 
ACT-2 CCAGAATCCATTGTgAATTCAG  PCR, reverse pACT1 (EcoRI site underlined) 
GSC-1 CTGAAGCTTTGGACGCA  PCR, forward GS-5 (HindIII site underlined) 
GSC-2 ACATCGATTATGGCTTC  PCR, reverse GS-5  (ClaI site underlined) 
GSL-1 CTGAAGCTTTGGACGCACCTGCTAT
AGCCGCAGCAAAAACAGCCGCAG
ATGCATTAGCTGCTGCCAA 
 PCR, forward GS-5 Synthesis. First extension 
(HindIII site underlined)  
GSL-2 ACATCGATTATGGCTTCGCCGCGGC
TGCAGCAGCATCAGCAGCAGTCTT
TTTGGCAGCAG 
 PCR, reverse GS-5 Synthesis. First extension 
(ClaI site underlined) 
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Figure 1 (Panadero et al., 2005) 
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Figure 2 (Panadero et al., 2005) 
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Figure 3 (Panadero et al., 2005) 
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Figure 4 (Panadero et al., 2005) 
